(Q44660764)

English

Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial

scientific article published on 9 June 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Tacrolimus is an alternative therapy option for the treatment of adult steroid-resistant nephrotic syndrome: a prospective, multicenter clinical trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

multicenter clinical trial

1 reference

based on heuristic

inferred from title

nephrotic syndrome

1 reference

based on heuristic

inferred from title

author name string

Li Fan

1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Qinghua Liu

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Yunhua Liao

3

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Zhibin Li

4

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Yulian Ji

5

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Zhenhua Yang

6

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Jian Chen

7

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Junzhou Fu

8

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Jinli Zhang

9

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Yaozhong Kong

10

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Ping Fu

11

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Tanqi Lou

12

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Zhengrong Liu

13

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Xueqing Yu

14

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Wei Chen

15

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

9 June 2012

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

International Urology and Nephrology

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

45

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

459-468

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Patients with mutations in NPHS2 (podocin) do not respond to standard steroid treatment of nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

NPHS2 mutation analysis shows genetic heterogeneity of steroid-resistant nephrotic syndrome and low post-transplant recurrence.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Adult minimal-change disease: clinical characteristics, treatment, and outcomes.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Proteinuria and the risk of developing end-stage renal disease

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Proteinuria as a surrogate outcome in CKD: report of a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Efficacy and safety of tacrolimus versus cyclosporine in children with steroid-resistant nephrotic syndrome: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Tacrolimus: a new therapy for steroid-resistant nephrotic syndrome in children

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Tacrolimus therapy in pediatric patients with treatment-resistant nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

FK 506 in steroid-resistant focal sclerosing glomerulonephritis of childhood.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Outcomes of tacrolimus therapy in adults with refractory membranous nephrotic syndrome: a prospective, multicenter clinical trial

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Use of tacrolimus in steroid- and cyclophosphamide-resistant minimal change nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

A renal allograft recipient with late recurrence of focal and segmental glomerulosclerosis after switching from cyclosporine to tacrolimus.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Combination therapy with sirolimus (rapamycin) and tacrolimus (FK-506) in treatment of refractory minimal change nephropathy, a clinical case report

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Treatment of focal and segmental glomerulosclerosis in adults with tacrolimus monotherapy

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Tacrolimus therapy in adults with steroid- and cyclophosphamide-resistant nephrotic syndrome and normal or mildly reduced GFR.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Combined therapy of tacrolimus and corticosteroids in cyclosporin-resistant or -dependent idiopathic focal glomerulosclerosis: a preliminary uncontrolled study with prospective follow-up

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

A randomized trial of cyclosporine in steroid-resistant idiopathic nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Treatment of the nephrotic syndrome associated with primary glomerulonephritis

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Clinical picture and outcome of primary focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Focal and segmental glomerulosclerosis: definition and relevance of a partial remission

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Urinary endothelin and renal vasoconstriction with cyclosporine or FK506 after liver transplantation.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A.

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

2007 Young Investigator Award: TRP'ing into a new era for glomerular disease

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Activation of NFAT signaling in podocytes causes glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Calcineurin (CN) activation promotes apoptosis of glomerular podocytes both in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS11255-012-0205-1

21 January 2018

Tacrolimus in steroid-resistant and steroid-dependent nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22684795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Tacrolimus treatment for steroid- and cyclosporin-resistant minimal-change nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22684795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pilot trial of FK 506 in the management of steroid-resistant nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22684795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic and renal hemodynamic differences between FK506 and cyclosporine in liver transplant recipients

1 reference

https://pubmed.ncbi.nlm.nih.gov/22684795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective tacrolimus treatment in a child suffering from severe nephrotic syndrome

1 reference

https://pubmed.ncbi.nlm.nih.gov/22684795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A meta-analysis and morphological review of cyclosporine-induced nephrotoxicity in auto-immune diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/22684795

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S11255-012-0205-1

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

5 December 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44660764&oldid=2031062158"